The Massachusetts Public Health Laboratory is accustomed to strong support from the CDC. Now it is learning to go it alone.

A new antibiotic called gepotidacin may soon offer a better way to treat gonorrhea, especially as traditional treatments become less effective. A recent large clinical trial, published in The ...

Super gonorrhea is not something good like Superman or Superwoman. It is a sexually transmitted bacteria that is resistant to most if not all the antibiotics that are currently available. It's ...

Key Takeaways. Layoffs at the U.S. Centers for Disease Control and Prevention included all 27 staff at the viral hepatitis ...

Researchers have reported the food attributable portions of disease for four important pathogens in the United Kingdom. Findings will be used to support future Food Standards Agency (FSA ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved since the 1990s.

Traditional composting often fails due to low lignocellulose degradation efficiency and the persistence of pathogens and antibiotic resistance genes (ARGs). Additionally, the use of antibiotics ...

These labs perform advanced disease testing and analysis on hepatitis to understand how it spreads, as well as track infections like chlamydia, syphilis, and gonorrhea. HealthDay News — Key labs ...

The following is a summary of “WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance,” ...

The same round of layoffs also shut down a CDC lab that tracked antibiotic-resistant gonorrhea, often called “super gonorrhea.” In all, 2,400 CDC employees were let go, The Post reported.